Production (Stage)
Pulmonx Corporation
LUNG
$3.11
-$0.01-0.32%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 19.54% | 23.28% | 15.39% | 20.87% | 29.71% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 19.54% | 23.28% | 15.39% | 20.87% | 29.71% |
| Cost of Revenue | 29.73% | 26.59% | 15.56% | 22.78% | 21.03% |
| Gross Profit | 16.08% | 22.15% | 15.33% | 20.21% | 32.95% |
| SG&A Expenses | 7.15% | 10.58% | 5.95% | 7.89% | 7.34% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 11.11% | 12.00% | 5.09% | 8.24% | 7.94% |
| Operating Income | -0.19% | 3.61% | 6.90% | 4.97% | 11.37% |
| Income Before Tax | -5.53% | 3.69% | 5.99% | 5.06% | 13.81% |
| Income Tax Expenses | -27.42% | -84.68% | 225.42% | -40.00% | 50.00% |
| Earnings from Continuing Operations | -5.08% | 5.13% | 5.07% | 5.37% | 13.31% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -5.08% | 5.13% | 5.07% | 5.37% | 13.31% |
| EBIT | -0.19% | 3.61% | 6.90% | 4.97% | 11.37% |
| EBITDA | -1.22% | 3.73% | 6.99% | 10.03% | 11.59% |
| EPS Basic | -1.60% | 8.01% | 7.88% | 8.10% | 15.68% |
| Normalized Basic EPS | -2.05% | 6.62% | 8.75% | 7.80% | 16.20% |
| EPS Diluted | -1.60% | 8.01% | 7.88% | 8.10% | 15.68% |
| Normalized Diluted EPS | -2.05% | 6.62% | 8.75% | 7.80% | 16.20% |
| Average Basic Shares Outstanding | 3.41% | 3.14% | 3.03% | 2.97% | 2.83% |
| Average Diluted Shares Outstanding | 3.41% | 3.14% | 3.03% | 2.97% | 2.83% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |